INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.220
+0.040 (3.39%)
Apr 13, 2026, 12:19 PM EDT - Market open
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $32.43 million as of April 13, 2026. Its market cap has decreased by -81.51% in one year.
Market Cap
32.43M
Enterprise Value
7.65M
1-Year Change
-81.51%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $32.43M, a decrease of -58.32%. That is a compound annual growth rate of -11.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 31.37M | -24.36% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 33.69M |
| Actinium Pharmaceuticals | 33.67M |
| Pluri | 33.37M |
| CEL-SCI | 32.94M |
| Plus Therapeutics | 32.94M |
| Dyadic International | 32.46M |
| Passage Bio | 31.73M |
| BriaCell Therapeutics | 30.73M |